The following is a list of selected recently published Expert Opinion articles, related to the content of this issue of Expert Opinion on Pharmacotherapy
Icatibant, the bradykinin B2 receptor antagonist with target to the interconnected kinin systems Delphine Charignon, Peter Späth, Ludovic Martin and Christian Drouet Expert Opinion on Pharmacotherapy Oct 2012, Vol. 13, No. 15, Pages 2233-2247 (doi:10.1517/14656566.2012.723692)
The emerging role of ALK inhibitors in the treatment of advanced non-small cell lung cancer Domenico Galetta, Antonio Rossi, Salvatore Pisconti and Giuseppe Colucci Expert Opinion on Therapeutic Targets Apr 2012, Vol. 16, No. S2, Pages S45-S54 (doi:10.1517/14728222.2011.642372)
Bevacizumab in endometrial cancer treatment Matteo Morotti, Mario Valenzano Menada, Pier Luigi Venturini and Simone Ferrero Expert Opinion on Biological Therapy May 2012, Vol. 12, No. 5, Pages 649-658 (doi:10.1517/14712598.2012.672558)
New therapeutic options in systemic treatment of advanced cutaneous melanoma Malgorzata Mackiewicz-Wysocka, Jakub Zolnierek and Piotr J Wysocki Expert Opinion on Investigational Drugs Feb 2013, Vol. 22, No. 2, Pages 181-190 (doi:10.1517/13543784.2013.748032)
Pharmacokinetic evaluation of rivaroxaban for the treatment of acute coronary syndromes Lakshmi Gopalakrishnan, Varun Kumar, Payal Kohli, Priyamvada Singh, Ujjwal Rastogi and C. Michael Gibson Expert Opinion on Drug Metabolism & Toxicology Jul 2012, Vol. 8, No. 7, Pages 889-900 (doi:10.1517/17425255.2012.688026)